Skip to content

Screener

Eligibility screening

Evaluate Soquelitinib in Participants With Moderate to Severe AD

Sponsored by Corvus Pharmaceuticals, Inc.Study detailsClinicalTrials.gov

1 US site in CA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.